|
|
Previous Article | Table of Contents | Next Article 
Identification of DNA rearrangements at the retinoic acid receptor- alpha
(RAR-alpha) locus in all patients with acute promyelocytic leukemia (APL)
and mapping of APL breakpoints within the RAR-alpha second intron. Italian
Cooperative Study Group "GIMEMA"
D Diverio, F Lo Coco, F D'Adamo, A Biondi, M Fagioli, F Grignani, A Rambaldi, V Rossi, G Avvisati and MC Petti
Human Biopathology Department, University La Sapienza, Roma, Italy.
Seventy patients with acute promyelocytic leukemia (APL) were characterized
at the DNA level using genomic retinoic acid receptor- alpha (RAR-alpha)
probes on Southern blot experiments. Sixty-two cases were defined as M3
according to the French-American-British (FAB) criteria, and eight had a
diagnosis of microgranular or variant (M3v) APL. The use of two restriction
enzymes and three probes exploring the second intron of the RAR-alpha gene
allowed us to detect specific abnormal DNA fragments in every case, with
clustering of rearrangements within the 20-kb intronic region between
RAR-alpha exons II and III. A more detailed mapping of APL breakpoints was
performed in 52 cases in which three EcoRI subregions of the RAR-alpha
second intron were analyzed with corresponding probes. Comparison of
clinical and hematological features in the three subgroups of patients with
distinct RAR-alpha breakpoints did not show significant differences
regarding age, peripheral blood (PB) counts, presence of coagulopathy, or
FAB classification (M3 v M3v). Interestingly, a significant difference was
observed in the M/F ratio of the three subgroups, with a higher incidence
of rearrangements at the 5' end of the RAR-alpha second intron in female
patients, and more frequent 3' breakpoints in males. The results of this
study indicate that a unique genomic alteration consistently occurs on the
17q- derivative of the APL specific t(15;17) aberration. Moreover, the
clinical relevance of RAR-alpha gene analysis both at diagnosis and in
follow-up studies is further emphasized.
Volume 79,
Issue 12,
pp. 3331-3336,
06/15/1992
Copyright © 1992 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. C. Petti, F. Fazi, M. Gentile, D. Diverio, P. De Fabritiis, M. S. De Propris, R. Fiorini, M. A. A. Spiriti, F. Padula, P. G. Pelicci, et al.
Complete remission through blast cell differentiation in PLZF/RARalpha -positive acute promyelocytic leukemia: in vitro and in vivo studies
Blood,
July 18, 2002;
100(3):
1065 - 1067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Latagliata, M. C. Petti, S. Fenu, M. Mancini, M. A. A. Spiriti, M. Breccia, G. A. Brunetti, G. Avvisati, F. L. Coco, and F. Mandelli
Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem
Blood,
February 1, 2002;
99(3):
822 - 824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Cote, D. Zhou, A. Bianchini, C. Nervi, R. E. Gallagher, and W. H. Miller Jr
Altered ligand binding and transcriptional regulation by mutations in the PML/RARalpha ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia
Blood,
November 1, 2000;
96(9):
3200 - 3208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Grimwade, A. Biondi, M.-J. Mozziconacci, A. Hagemeijer, R. Berger, M. Neat, K. Howe, N. Dastugue, J. Jansen, I. Radford-Weiss, et al.
Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party
Blood,
August 15, 2000;
96(4):
1297 - 1308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Arnould, C. Philippe, V. Bourdon, M. J. Gregoire, R. Berger, and P. Jonveaux
The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor {alpha} in acute promyelocytic-like leukaemia
Hum. Mol. Genet.,
September 1, 1999;
8(9):
1741 - 1749.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Imaizumi, H. Suzuki, M. Yoshinari, A. Sato, T. Saito, A. Sugawara, S. Tsuchiya, Y. Hatae, T. Fujimoto, A. Kakizuka, et al.
Mutations in the E-Domain of RARalpha Portion of the PML/RARalpha Chimeric Gene May Confer Clinical Resistance to All-trans Retinoic Acid in Acute Promyelocytic Leukemia
Blood,
July 15, 1998;
92(2):
374 - 382.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Jennings and K. A. Foon
Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy
Blood,
October 15, 1997;
90(8):
2863 - 2892.
[Full Text]
[PDF]
|
 |
|
|
|